Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
2.
Paediatr Respir Rev ; 38: 24-32, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32980274

RESUMEN

Exercise induced dyspnoea (EID) is a common manifestation in children and adolescents. Although EID is commonly attributed to exercise induced bronchoconstriction, several conditions other than asthma can cause EID in otherwise healthy children and adolescents. Cardiopulmonary exercise testing (CPET) offers a non-invasive comprehensive assessment of the cardiovascular, ventilatory and metabolic responses to exercise and is a powerful diagnostic and prognostic tool. CPET is a reproducible, non-invasive form of testing that allows for comparison against age- and gender-specific norms. CPET can assess the child's exercise capacity, determine the limiting factors associated with this, and be used to prescribe individualised interventions. EID can occur due to asthma, exercise induced laryngeal obstruction, breathing pattern disorders, chest wall restriction and cardiovascular pathology among other causes. Differentiating between these varied causes is important if effective therapy is to be initiated and quality of life improved in subjects with EID.


Asunto(s)
Prueba de Esfuerzo , Enfermedades de la Laringe , Adolescente , Broncoconstricción , Niño , Disnea/diagnóstico , Disnea/etiología , Humanos , Calidad de Vida
3.
Accid Anal Prev ; 144: 105595, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32534288

RESUMEN

There is extensive literature into the mechanisms of injury in traffic crashes involving vulnerable road users (VRUs), but little research into the social or psychological factors in causation in these crash types. Attitudes and emotional associations can affect how people attend to objects in their visual environment and physical approach/avoidance responses, but few studies have extended these approaches into the road safety domain. Existing driving simulator studies of driver-bicyclist interactions have focused on driver behavior but not underlying attitudes and their effect on safety-related behaviors. This research explored the impact of implicit and explicit attitudes on drivers' behavior in interactions with bicyclists. In a driving simulator, various objective measures of safety (e.g., speed, passing distance, crash occurrence) were collected in an overtaking scenario. Participants' self-reported attitudes about driving and bicyclists were collected via survey instrument, along with an online test of subconscious attitudes called an Implicit Association Test, developed to examine preference between drivers and bicyclists. Importantly, this study examined not only distance, but duration and speed during overtaking. Results demonstrate that conscious attitudes affect how quickly and closely drivers overtake bicyclists. Participants who hold negative attitudes about bicyclists as a legitimate road user group passed significantly faster, while people with concerns about their knowledge or judgment about overtaking a bicyclist passed further and more slowly. Drivers self-identification as a bicyclist predicted higher passing speeds, while respondents who bicycle weekly drove closer but more slowly to the simulated bicyclist. These behaviors did not significantly differ based on the measure of implicit attitudes. The results of this study provide potential avenues for infrastructure and education interventions to improve pedestrian and bicyclist safety. Additionally, pairing driving simulator behavior with attitudinal measures represents a significant methodological contribution.


Asunto(s)
Conducción de Automóvil/psicología , Ciclismo/psicología , Accidentes de Tránsito/prevención & control , Adulto , Simulación por Computador , Femenino , Humanos , Masculino , Autoinforme
4.
Int J Stroke ; 13(9): 949-984, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30021503

RESUMEN

The 2018 update of the Canadian Stroke Best Practice Recommendations for Acute Stroke Management, 6th edition, is a comprehensive summary of current evidence-based recommendations, appropriate for use by healthcare providers and system planners caring for persons with very recent symptoms of acute stroke or transient ischemic attack. The recommendations are intended for use by a interdisciplinary team of clinicians across a wide range of settings and highlight key elements involved in prehospital and Emergency Department care, acute treatments for ischemic stroke, and acute inpatient care. The most notable changes included in this 6th edition are the renaming of the module and its integration of the formerly separate modules on prehospital and emergency care and acute inpatient stroke care. The new module, Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care is now a single, comprehensive module addressing the most important aspects of acute stroke care delivery. Other notable changes include the removal of two sections related to the emergency management of intracerebral hemorrhage and subarachnoid hemorrhage. These topics are covered in a new, dedicated module, to be released later this year. The most significant recommendation updates are for neuroimaging; the extension of the time window for endovascular thrombectomy treatment out to 24 h; considerations for treating a highly selected group of people with stroke of unknown time of onset; and recommendations for dual antiplatelet therapy for a limited duration after acute minor ischemic stroke and transient ischemic attack. This module also emphasizes the need for increased public and healthcare provider's recognition of the signs of stroke and immediate actions to take; the important expanding role of paramedics and all emergency medical services personnel; arriving at a stroke-enabled Emergency Department without delay; and launching local healthcare institution code stroke protocols. Revisions have also been made to the recommendations for the triage and assessment of risk of recurrent stroke after transient ischemic attack/minor stroke and suggested urgency levels for investigations and initiation of management strategies. The goal of this updated guideline is to optimize stroke care across Canada, by reducing practice variations and reducing the gap between current knowledge and clinical practice.


Asunto(s)
Servicios Médicos de Urgencia/legislación & jurisprudencia , Servicio de Urgencia en Hospital/legislación & jurisprudencia , Ataque Isquémico Transitorio/terapia , Accidente Cerebrovascular/terapia , Canadá , Cuidados Críticos/legislación & jurisprudencia , Atención a la Salud/legislación & jurisprudencia , Hospitalización/legislación & jurisprudencia , Humanos , Pacientes Internos , Accidente Cerebrovascular/diagnóstico
5.
Epidemiol Infect ; 145(12): 2445-2457, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28737119

RESUMEN

Passive surveillance for lyssaviruses in UK bats has been ongoing since 1987 and has identified 13 cases of EBLV-2 from a single species; Myotis daubentonii. No other lyssavirus species has been detected. Between 2005 and 2015, 10 656 bats were submitted, representing 18 species, creating a spatially and temporally uneven sample of British bat fauna. Uniquely, three UK cases originate from a roost at Stokesay Castle in Shropshire, England, where daily checks for grounded and dead bats are undertaken and bat carcasses have been submitted for testing since 2007. Twenty per cent of Daubenton's bats submitted from Stokesay Castle since surveillance began, have tested positive for EBLV-2. Phylogenetic analysis reveals geographical clustering of UK viruses. Isolates from Stokesay Castle are more closely related to one another than to viruses from other regions. Daubenton's bats from Stokesay Castle represent a unique opportunity to study a natural population that appears to maintain EBLV-2 infection and may represent endemic infection at this site. Although the risk to public health from EBLV-2 is low, consequences of infection are severe and effective communication on the need for prompt post-exposure prophylaxis for anyone that has been bitten by a bat is essential.


Asunto(s)
Quirópteros , Lyssavirus/aislamiento & purificación , Infecciones por Rhabdoviridae/veterinaria , Animales , Monitoreo Epidemiológico/veterinaria , Proteínas de la Nucleocápside/genética , Filogenia , Infecciones por Rhabdoviridae/epidemiología , Infecciones por Rhabdoviridae/virología , Análisis de Secuencia de ADN/veterinaria , Reino Unido/epidemiología
8.
Dis Esophagus ; 25(4): 349-55, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22409514

RESUMEN

The management of high-grade dysplasia in Barrett's esophagus has clearly changed over recent years. The risk of cancer development is still substantial, with about one in three patients developing cancer, but a number of patients do not develop cancer. The nature of high-grade dysplasia has also been genetically elucidated with more evidence of chromosomal instability being present at this stage than previously thought. Therapy of the condition has evolved more toward endoscopic therapy, given the good results of radio-frequency ablation and photodynamic therapy in eliminating dysplasia and decreasing cancer development in randomized controlled trial. The best candidates for treatment include compliant patients that have relatively short segments of Barrett's esophagus, an anatomically straight segment, lack of nodularity, and an intact p16. However, even with excellent long-term results similar to surgical resection, the risk of recurrence is present in over 14% of patients, which indicates that there will be a need to continue surveillance endoscopy in these patients.


Asunto(s)
Esófago de Barrett/terapia , Ablación por Catéter , Esofagoscopía , Fotoquimioterapia , Lesiones Precancerosas/terapia , Esófago de Barrett/genética , Esófago de Barrett/metabolismo , Esófago de Barrett/patología , Biomarcadores/metabolismo , Perfilación de la Expresión Génica , Humanos , Membrana Mucosa/cirugía , Lesiones Precancerosas/genética , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/patología
9.
J Med Virol ; 82(7): 1255-65, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20513093

RESUMEN

A 37-year-old woman was admitted to hospital and over the next 5 days developed a progressive encephalitis. Nuchal skin biopsy, analyzed using a Rabies TaqMan(c) PCR, demonstrated rabies virus RNA. She had a history in keeping with exposure to rabies whilst in South Africa, but had not received pre- or post-exposure prophylaxis. She was treated with a therapeutic coma according to the "Milwaukee protocol," which failed to prevent the death of the patient. Rabies virus was isolated from CSF and saliva, and rabies antibody was demonstrated in serum (from day 11 onwards) and cerebrospinal fluid (day 13 onwards). She died on day-35 of hospitalization. Autopsy specimens demonstrated the presence of rabies antigen, viral RNA, and viable rabies virus in the central nervous system.


Asunto(s)
Terapia Convulsiva , Virus de la Rabia/aislamiento & purificación , Rabia/diagnóstico , Adulto , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/líquido cefalorraquídeo , Antígenos Virales/análisis , Resultado Fatal , Femenino , Humanos , Pruebas de Neutralización , ARN Viral/análisis , Rabia/sangre , Rabia/terapia , Rabia/virología , Virus de la Rabia/genética , Virus de la Rabia/inmunología , Saliva/virología , Sudáfrica
10.
Arch Virol ; 155(7): 1175-7, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20490607

RESUMEN

Between October 2008 and May 2009, five brain samples from the carcasses of the rare Ethiopian wolf (Canis simenensis) were submitted for rabies virus testing. Rabies virus was detected in all five samples, and this confirmed that a further outbreak of rabies had occurred within the wolf population in the Bale Mountains of Ethiopia. Sequence comparison of a partial fragment of the nucleoprotein-coding gene demonstrated that all viruses showed 100% sequence identity, suggesting a single introduction of rabies virus.


Asunto(s)
Brotes de Enfermedades/veterinaria , Rabia/veterinaria , Lobos , Animales , Encéfalo/virología , Etiopía/epidemiología , Filogenia , Rabia/epidemiología , Virus de la Rabia/genética , Virus de la Rabia/aislamiento & purificación
11.
AJNR Am J Neuroradiol ; 30(9): 1778-9, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19369611

RESUMEN

Brown syndrome describes the inability of a patient to perform an upward gaze while the eye is adducted due to an abnormality of the superior oblique tendon sheath complex. Use of CT in diagnosing the condition has been reported; however, the use of MR imaging has not. We describe a unique case of Brown syndrome in which the initial CT findings were normal, but MR imaging revealed the abnormality. Key imaging features are illustrated.


Asunto(s)
Imagen por Resonancia Magnética/métodos , Trastornos de la Motilidad Ocular/congénito , Trastornos de la Motilidad Ocular/diagnóstico , Músculos Oculomotores/anomalías , Músculos Oculomotores/patología , Tendones/anomalías , Tendones/patología , Femenino , Humanos , Persona de Mediana Edad , Síndrome
12.
AJNR Am J Neuroradiol ; 29(2): 217-23, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18184832

RESUMEN

BACKGROUND AND PURPOSE: Coated coils have been in clinical use for several years without robust evidence to determine their safety/efficacy. The HydroCoil Endovascular Aneurysm Occlusion and Packing Study (HELPS) addresses this deficiency for the HydroCoil embolic system. This article reports periprocedural safety/operator-assessed angiographic results from HELPS. MATERIALS AND METHODS: Patients were randomized to the hydrogel coil or control arms by using concealed allocation with minimization matching groups. Any bare platinum coils were allowed in the control arm, and assist devices could be used as clinically required. Both recently ruptured and not recently ruptured/unruptured aneurysms were included. Analysis was on an intention-to-treat basis. RESULTS: Four hundred ninety-nine patients were recruited. Coiling was successful in 98.6%. Mean aneurysm size was 6.5 mm (26% were > or =10 mm), 53% were recently ruptured aneurysms, and an assist device was used in 46%. Seventy procedural adverse events were reported in hydrogel coils and 86 in control arms. The 3-month mortality rate was 3.6% in hydrogel coils and 2.0% in control arms; the difference was not significant (P = .6). There was a lower 2-month mortality rate in the HELPS subarachnoid hemorrhage cohort (4.1%) than would be anticipated from the International Subarachnoid Aneurysm Trial (7%). There was a trend toward increased adverse events when assist devices were used, which was substantial for stents deployed in recently ruptured aneurysms. Ninety-six percent of patients discharged were World Federation of Neurosurgeons grade 0-2 at discharge. No difference was found between arms in the operator assessment of angiographic occlusions (P = .3). CONCLUSION: These HELPS results reinforce coiling as an effective treatment for aneurysms, with an excellent technical success rate. Hydrogel coils can be used in a wide spectrum of aneurysms with a risk profile equivalent to that of bare platinum.


Asunto(s)
Embolización Terapéutica/instrumentación , Embolización Terapéutica/estadística & datos numéricos , Aneurisma Cardíaco/mortalidad , Aneurisma Cardíaco/terapia , Hidrocefalia/mortalidad , Medición de Riesgo/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Comorbilidad , Femenino , Aneurisma Cardíaco/diagnóstico por imagen , Humanos , Hidrocefalia/diagnóstico por imagen , Incidencia , Masculino , Persona de Mediana Edad , Radiografía , Factores de Riesgo , Prevención Secundaria , Análisis de Supervivencia , Tasa de Supervivencia , Resultado del Tratamiento , Reino Unido/epidemiología
13.
J Virol Methods ; 117(1): 1-8, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15019254

RESUMEN

A protocol suitable for the detection of rabies virus-specific antibodies in serum samples from companion animals using an enzyme linked immunosorbent assay (ELISA) is described. This method has been used successfully for the qualitative assessment of rabies virus-specific antibodies in serum samples from a cohort of vaccinated dogs and cats. In two initial field studies, a variable population of field samples from the Veterinary Laboratories Agency (VLA), United Kingdom were tested. In the first study (n = 1000), the number of false-positive and false-negative results was 11 samples (1.1%) and 67 samples (6.7%), respectively. In the second study (n = 920), the number of false-positive and false-negative results was 7 samples (0.8%) and 52 samples (5.7%). In a third study, undertaken at l'Agence Française de Sécurité Sanitaire des Aliments (AFSSA), Nancy, France (n = 440), 1 false-positive sample (0.23%) and 91 (20.7%) false-negative samples were identified. Data generated using this prototype ELISA indicate a strong correlation for specificity when compared to the gold standard fluorescent antibody virus neutralisation (FAVN) test. Although the ELISA has a lower sensitivity than the FAVN test, it is a useful tool for rapidly screening serum samples from vaccinated companion animals. Using a cut-off value of 0.6 EU/ml, the sensitivity (R = % from VLA and 79% from AFSSA) and specificity (R = 97.3%) indices between the ELISA compared favourably with data generated using the FAVN test. The major advantages of the ELISA test are that it is a qualitative tool that can be completed in four hours, does not require the use of live virus and can be performed without the need for specialised laboratory containment. This contrasts with 4 days using conventional rabies antibody virus neutralisation assays. Using the current format, the ELISA assay described would be a valuable screening tool for the detection of rabies antibodies from vaccinated domestic animals in combination with other Office International des Epizooties (OIE) accepted serological tests.


Asunto(s)
Anticuerpos Antivirales/sangre , Gatos/inmunología , Perros/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Vacunas Antirrábicas , Virus de la Rabia/inmunología , Rabia/inmunología , Animales , Ensayo de Inmunoadsorción Enzimática/veterinaria , Sensibilidad y Especificidad
15.
Healthc Financ Manage ; 54(8): 41-7, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11010196

RESUMEN

Financial managers of managed care organizations should structure their compliance plans to conform with requirements shaped by forces such as judicial decisions and extralegal standards for managed care operations, in addition to state and Federal laws and regulations. In addition to researching the law and training employees, an integral compliance plan should include monitoring organizational systems that can encourage or impede compliance, measuring employees' motivation to adhere to compliance standards, and modifying corporate culture to support compliance goals. Managed care organizations should empower compliance officers with a broad range of tools to assess and improve compliance efforts, or risk having organizational decisions examined externally through the lens of an onerous, dynamic system of laws and judicial decisions.


Asunto(s)
Adhesión a Directriz/organización & administración , Programas Controlados de Atención en Salud/organización & administración , Modelos Organizacionales , Personal Administrativo , Regulación y Control de Instalaciones , Adhesión a Directriz/legislación & jurisprudencia , Responsabilidad Legal , Programas Controlados de Atención en Salud/legislación & jurisprudencia , Programas Controlados de Atención en Salud/normas , Cultura Organizacional , Competencia Profesional , Gestión de la Calidad Total , Estados Unidos
16.
Interv Neuroradiol ; 5(3): 265-6, 1999 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-20670521
18.
J Nucl Med ; 19(4): 419-21, 1978 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-632932

RESUMEN

Xenon-127, which provides photon energies better suited to the Anger camera and reduces radiation dosage to the patient compared with Xe-133, has become commercially available from Brookhaven Laboratories. Its higher cost and longer shelf-life require improved handling and dispensing of shipment ampoules containing gas of high specific activity. The technique described permits individual doses to be prepared for gaseous administration, or dissolved in saline for i.v. injection.


Asunto(s)
Pruebas de Función Respiratoria/instrumentación , Radioisótopos de Xenón
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...